@dylanarmbruste3 @MyNutritionSci I assumed OP was talking about pre-specified analysis vs post hoc exploratory as some post hoc findings dont have explantion behind the effect found in the post hoc study eg- https://t.co/Vt0sEW90mf
RT @BJGPjournal: No. 7 Oseltamivir for coronavirus – Patients testing positive for coronavirus recovered sooner with oseltamivir. #BJGPTop1…
RT @BJGPjournal: No. 7 Oseltamivir for coronavirus – Patients testing positive for coronavirus recovered sooner with oseltamivir. #BJGPTop1…
RT @BJGPjournal: No. 7 Oseltamivir for coronavirus – Patients testing positive for coronavirus recovered sooner with oseltamivir. #BJGPTop1…
RT @PREPARE_EUROPE: We are proud to announce that the @PREPARE_EUROPE study about Oseltamivir for #coronavirus illness, made it to the 7th…
RT @PREPARE_EUROPE: We are proud to announce that the @PREPARE_EUROPE study about Oseltamivir for #coronavirus illness, made it to the 7th…
RT @BJGPjournal: No. 7 Oseltamivir for coronavirus – Patients testing positive for coronavirus recovered sooner with oseltamivir. #BJGPTop1…
RT @PREPARE_EUROPE: We are proud to announce that the @PREPARE_EUROPE study about Oseltamivir for #coronavirus illness, made it to the 7th…
RT @PREPARE_EUROPE: We are proud to announce that the @PREPARE_EUROPE study about Oseltamivir for #coronavirus illness, made it to the 7th…
RT @PREPARE_EUROPE: We are proud to announce that the @PREPARE_EUROPE study about Oseltamivir for #coronavirus illness, made it to the 7th…
We are proud to announce that the @PREPARE_EUROPE study about Oseltamivir for #coronavirus illness, made it to the 7th place of most read research in the @BJGPjournal #BJGPTop10 @ProfHGoossens @theo_verheij @ChrisColButler @dr_nina_g @DanielaCianci https:
No. 7 Oseltamivir for coronavirus – Patients testing positive for coronavirus recovered sooner with oseltamivir. #BJGPTop10 @HRBPrimaryCare @ProfHGoossens @theo_verheij @ChrisColButler @dr_nina_g @UAntwerpen_FGGW @DanielaCianci https://t.co/muPerB6v41 http
RT @HRBPrimaryCare: New publication evaluating oseltamivir for coronavirus in a pragmatic RCT in primary care (though not COVID-19). Publ…
New publication evaluating oseltamivir for coronavirus in a pragmatic RCT in primary care (though not COVID-19). Published in @BJGPjournal, co-authored by our own Dr Muireann De Paor @RCSI_Irl. https://t.co/d3FXCyvmzn https://t.co/7w7kqlCxSQ
@nastynaboka Primary care patients with ILI testing positive for coronavirus (not including SARS-CoV-2) recovered sooner when oseltamivir was added to usual care compared with usual care alone. This may be of relevance to the primary care management of COV
The mean number of days to recovery for patients was 6.35 days (standard deviation [SD] = 4.93) in the usual care group and 5.20 (SD = 3.93) days in the oseltamivir group. The HR was 1.31 (95% CI = 1.03 to 1.66, P = 0.026) favouring oseltamivir. https://t
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018 https://t.co/vxvtYY675q
RT @BJGPjournal: Primary care patients with flu-like illness testing positive for coronavirus infection (not including SARS-CoV-2) recovere…
RT @VictimOfMaths: I'm not an expert on survival curve analysis, but this trial of Oseltamivir (aka Tamiflu) for COVID-19 looks, erm, under…
RT @BJGPjournal: Primary care patients with flu-like illness testing positive for coronavirus infection (not including SARS-CoV-2) recovere…
I'm not an expert on survival curve analysis, but this trial of Oseltamivir (aka Tamiflu) for COVID-19 looks, erm, underwhelming.
RT @BJGPjournal: Primary care patients with flu-like illness testing positive for coronavirus infection (not including SARS-CoV-2) recovere…
Might Oseltamivir work for SARS-CoV-2?
Primary care patients with flu-like illness testing positive for coronavirus infection (not including SARS-CoV-2) recovered sooner when treated with oseltamivir. Oseltamivir might be considered for the primary care management of suspected COVID-19. https:/